Cue Biopharma Inc investor relations material

Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. The company is focused on developing its proprietary platform designed to modulate immune signaling with cytokine infiltration and inflammatory mediators to generate personalized therapeutic immunotherapies.